Design Therapeutics, Inc. (DSGN)
DSGN has a market cap or net worth of $635.92 million. The enterprise value is $267.71 million.
The latest earnings date was Monday, May 9, 2022, before market open.
|Last Earnings Date||May 9, 2022|
DSGN has 55.78 million shares outstanding. The number of shares has increased by 214.84% in one year.
|Shares Change (YoY)||+214.84%|
|Shares Change (QoQ)||+20.84%|
|Owned by Insiders (%)||36.84%|
|Owned by Institutions (%)||68.31%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 68.23, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -11.20%, which is considered low. The company has a ROIC of -69.20%.
|Return on Equity (ROE)||-11.20%|
|Return on Assets (ROA)||-11.00%|
|Return on Capital (ROIC)||-69.20%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$983,727|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-58.45%|
|50-Day Moving Average||13.18|
|200-Day Moving Average||15.73|
|Average Volume (30 Days)||157,535|
Short Selling Information
The latest short interest is 4.06 million, so 7.29% of the outstanding shares have been sold short.
|Short % of Shares Out||7.29%|
|Short % of Float||23.00%|
|Short Ratio (days to cover)||28.83|
|Earnings Per Share (EPS)||-$0.78|
The company has $371.22 million in cash and $3.01 million in debt, giving a net cash position of $368.21 million or $6.60 per share.
|Cash & Cash Equivalents||371.22M|
|Net Cash Per Share||$6.60|
|Book Value Per Share||6.64|
In the last 12 months, operating cash flow was -$37.51 million and capital expenditures -$1.58 million, giving a free cash flow of -$39.09 million.
|Operating Cash Flow||-37.51M|
|Free Cash Flow||-39.09M|
|FCF Per Share||n/a|
Dividends & Yields
DSGN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for DSGN is $28.05, which is 146.05% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||146.05%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|